| CXSL2400018 | 人干扰素α2b阴道泡腾片 | Recombinant Human Interferon α2b | Tablet | Biological Products(2.2) | New Drug Application | 2024-01-10 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CXSL2400016 | 人干扰素α2b阴道泡腾片 | Recombinant Human Interferon α2b | Tablet | Biological Products(2.2) | New Drug Application | 2024-01-09 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CXSL2300345 | 培集成干扰素α-2注射液 | Peginterferon alfacon-2 | Injection | Biological Products(2.2) | New Drug Application | 2023-05-17 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CXSB2300020 | 培集成干扰素α-2注射液 | Peginterferon alfacon-2 | Injection | Biological Products | Supplementary Application | 2023-02-25 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CXSL2300038 | KW-027注射液 | KW-027 | Injection | Biological Products(1) | New Drug Application | 2023-01-13 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CXSL2200464 | 培集成干扰素α-2注射液 | Peginterferon alfacon-2 | Injection | Biological Products(2.2) | New Drug Application | 2022-09-16 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CXSL2200459 | 人干扰素α2b喷雾剂 | | Spray | Biological Products(2.2) | New Drug Application | 2022-09-14 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CYSB2200225 | 培集成干扰素α-2注射液 | Peginterferon alfacon-2 | Injection | Biological Products | Supplementary Application | 2022-09-09 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CYSB2200184 | 人干扰素α2b阴道泡腾片 | Recombinant Human Interferon α2b | Tablet | Biological Products | Supplementary Application | 2022-07-28 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CYHB2250441 | 复方甘草酸苷片 | Glycyrrhizin;Glycine;DL-Methionine | Tablet | Chemical Drugs(原6) | Supplementary Application | 2022-07-15 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CYHB2101714 | 盐酸纳洛酮注射液 | naloxone hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2021-08-23 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CYHB2101716 | 盐酸纳洛酮注射液 | naloxone hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2021-08-23 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CYHB2101717 | 盐酸纳洛酮注射液 | naloxone hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2021-08-23 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CYHB2101715 | 盐酸纳洛酮注射液 | naloxone hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2021-08-23 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CXSL2000361 | XW003注射液 | XW003 | Injection | Biological Products(1) | New Drug Application | 2020-12-16 | 杭州先为达生物科技有限公司；北京凯因科技股份有限公司 | | In Review | 2020-12-15 | view |
| CYHB2004474 | 索磷布韦片 | Sofosbuvir | Tablet | Chemical Drugs | Supplementary Application | 2020-06-13 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2020-09-16 | view |
| CYHB1902857 | 盐酸纳洛酮注射液 | naloxone hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2019-05-30 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2019-08-30 | view |
| CYHB1902858 | 盐酸纳洛酮注射液 | naloxone hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2019-05-29 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2019-08-30 | view |
| CYHB1902860 | 盐酸纳洛酮注射液 | naloxone hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2019-05-29 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2019-08-30 | view |
| CYHB1902859 | 盐酸纳洛酮注射液 | naloxone hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2019-05-29 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2019-08-30 | view |
